Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Experimental & Molecular Medicine ; : 479-485, 2008.
Article Dans Anglais | WPRIM | ID: wpr-84655

Résumé

Hypoxia-inducible factor 1alpha (HIF-1alpha) is rapidly degraded by the ubiquitin-proteasome pathway under normoxic conditions. Ubiquitination of HIF-1alpha is mediated by interaction with von Hippel-Lindau tumor suppressor protein (pVHL). In our previous report, we found that hypoxia-induced active signal transducer and activator of transcription3 (STAT3) accelerated the accumulation of HIF-1alpha protein and prolonged its half-life in solid tumor cells. However, its specific mechanisms are not fully understood. Thus, we examined the role of STAT3 in the mechanism of pVHL-mediated HIF-1alpha stability. We found that STAT3 interacts with C-terminal domain of HIF-1alpha and stabilizes HIF-1alpha by inhibition of pVHL binding to HIF-1alpha. The binding between HIF-1alpha and pVHL, negative regulator of HIF-1alpha stability, was interfered dose-dependently by overexpressed constitutive active STAT3. Moreover, we found that the enhanced HIF-1alpha protein levels by active STAT3 are due to decrease of poly-ubiquitination of HIF-1alpha protein via inhibition of interaction between pVHL and HIF-1alpha. Taken together, our results suggest that STAT3 decreases the pVHL-mediated ubiquitination of HIF-1alpha through competition with pVHL for binding to HIF-1alpha, and then stabilizes HIF-1alpha protein levels.


Sujets)
Animaux , Humains , Cellules COS , Lignée cellulaire tumorale , Chlorocebus aethiops , Sous-unité alpha du facteur-1 induit par l'hypoxie/génétique , Immunotransfert , Immunoprécipitation , Liaison aux protéines , Facteur de transcription STAT-3/génétique , Transduction du signal/génétique , Transfection , Ubiquitination , Protéine Von Hippel-Lindau supresseur de tumeur/génétique
2.
Experimental & Molecular Medicine ; : 417-427, 2006.
Article Dans Anglais | WPRIM | ID: wpr-53148

Résumé

To elucidate the roles of 8-hydroxydeoxyguanosine (oh8dG), the nucleoside of 8-hydroxyguanine (oh8Gua), we examined the effects of oh8dG upon LPS-induced intercellular adhesion molecule-1 (ICAM-1) expression and the underlying mechanisms in brain microglial cells. We found that oh8dG reduces LPS-induced reactive oxygen species (ROS) production, STAT3 activation, and ICAM-1 expression. oh8dG also suppresses pro-inflammatory cytokines, such as TNF-alpha, IL-6 and IFN-gamma. Overexpression of dominant negative STAT3 completely diminshed STAT3-mediated ICAM-1 transcriptional activity. Chromatin immunoprecipitation studies revealed that oh8dG inhibited recruitment of STAT3 to the ICAM-1 promoter, followed by a decrease in ICAM-1 expression. Using mice lacking a functional Toll-like receptor 4 (TLR4), we demonstrated that, while TLR4+/+ microglia were activated by LPS, TLR4-/-microglia exhibited inactivated STAT3 in response to LPS. Evidently, LPS modulates STAT3-dependent ICAM-1 induction through TLR4-mdiated cellular responses. Oh8dG apparently plays a role in anti-inflammatory actions via suppression of ICAM-1 gene expression by blockade of the TLR4-STAT3 signal cascade in inflammation-enhanced brain microglia. Therefore, oh8dG in the cytosol probably functions as an anti-inflammatory molecule and should be considered as a candidate for development of anti-inflammatory agents.


Sujets)
Souris , Mâle , Animaux , Récepteur de type Toll-4/génétique , Facteur de transcription STAT-3/physiologie , Espèces réactives de l'oxygène/métabolisme , Microglie/effets des médicaments et des substances chimiques , Souris knockout , Souris de lignée C57BL , Lipopolysaccharides/pharmacologie , Molécule-1 d'adhérence intercellulaire/métabolisme , Médiateurs de l'inflammation/métabolisme , Encéphalite/traitement médicamenteux , Désoxyguanosine/analogues et dérivés , Cytokines/biosynthèse , Survie cellulaire/effets des médicaments et des substances chimiques , Encéphale/cytologie , Anti-inflammatoires non stéroïdiens/pharmacologie
3.
Immune Network ; : 23-29, 2005.
Article Dans Anglais | WPRIM | ID: wpr-127003

Résumé

BACKGROUND: Interleukin-7 receptor (IL-7R) alpha-deficient mice have small numbers of B cells and alpha beta T cells in periphery, they totally lack gamma sigma T cells. In addition, the V-J recombination and transcription of TCRgamma genes is also severely impaired in IL-7Ralpha-deficient mice. Stat5, a signaling molecule of the IL-7R, induces germline transcription in the TCRgamma locus, and promotes V-J recombination and gamma sigma T cell development. However, the roles for IL-7R signaling pathway in thymic or extrathymic gamma sigma T cell development are largely unknown. METHODS: To clarify the role of the IL-7 receptor in proliferation and survival of gamma sigma T cells, we introduced the TCR gamma sigma transgene, Vgamma2/ Vsigma5, into IL-7Ralpha-deficient mice, and investigated the development of gamma sigma T cells. RESULTS: We found that Vgamma2/Vsigma5 transgene restored gamma sigma T cells in the epithelium of the small intestine (IEL) but not in the thymus and the spleen. Further addition of a bcl-2 transgene resulted in partial recovery of gamma sigma T cells in the thymus and the spleen of these mice. CONCLUSION: Taken together, this study revealed that the IL-7Ralpha is indispensable for proliferation and survival mainly in thymic gamma sigma T cell development.


Sujets)
Animaux , Souris , Lymphocytes B , Épithélium , Interleukine-7 , Intestin grêle , Récepteurs à l'interleukine-7 , Recombinaison génétique , Rate , Lymphocytes T , Thymus (glande) , Transgènes
SÉLECTION CITATIONS
Détails de la recherche